Molecular Medicine and Biomedical Research in the Era of Precision Medicine
New Technologies and Personalized Drug Therapies for Patient Care
Herausgeber: Sobti, Ranbir Chander; Sobti, Aastha; G Telessy, Istvan; S Buttar, Harpal; W Wilson, Douglas
Molecular Medicine and Biomedical Research in the Era of Precision Medicine
New Technologies and Personalized Drug Therapies for Patient Care
Herausgeber: Sobti, Ranbir Chander; Sobti, Aastha; G Telessy, Istvan; S Buttar, Harpal; W Wilson, Douglas
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care provides researchers with an extensive overview of recent advances in molecular biology impacting the development of targeted therapies. The book delivers insights into the pathobiological and pathogenetic mechanisms of various diseases, providing a detailed study of the latest personalized interventions to be implemented across such conditions. It covers a range of technologies, including RNA-sequencing, AI, Machine Learning, gene therapy, omics and…mehr
- Advances in Protein Molecular and Structural Biology Methods151,99 €
- Open Electronic Data Capture Tools for Medical and Biomedical Research and Medical Allied Professionals156,99 €
- R Holland ChengConformational Proteomics of Macromolecular Architecture: Approaching the Structure of Large Molecular Assemblies and Their Mechanisms of Action190,99 €
- SAUNDERSAnalytical Molecular Biology123,99 €
- Chao-Hung LeeApplied Molecular Biology34,99 €
- Arnon CohenBiomedical Signal Processing76,99 €
- P. RevestMolecular Neuroscience38,99 €
-
-
-
- Produktdetails
- Verlag: Elsevier Science
- Seitenzahl: 600
- Erscheinungstermin: 1. Januar 2025
- Englisch
- ISBN-13: 9780443223006
- ISBN-10: 0443223009
- Artikelnr.: 70889990
- Verlag: Elsevier Science
- Seitenzahl: 600
- Erscheinungstermin: 1. Januar 2025
- Englisch
- ISBN-13: 9780443223006
- ISBN-10: 0443223009
- Artikelnr.: 70889990
delivery, and their roles in biomedical sciences Introduction and Preface
Section II: Technologies in biomedicine and molecular medicine
A: Basic and emerging technologies
1. Single-cell RNA-seq technologies in biomedical studies and their
potential clinical applications
2. Next-generation sequencing (NGS), OMICS and gene editing technologies:
Their role in biomedical sciences
3. Artificial intelligence in molecular medicine
4. Role of modern scientific technologies and innovations for augmenting
health care and precision in health care system
5. Machine Learning in the field of health care using medical images
6. Role of computer assisted prediction models in disease prevention
7. Physiological studies on the usefulness of chips
8. Bioinformatics as a tool for biomedical innovations
9. Molecular Epidemiological approach in disease management
10. Novel aspects of personalized medicines, patient care and management
11. Stem cells and Gene Therapy in disease management
12. Role of telemedicine in point of care treatment of patients
B: Application of technology in some diseases
13. Machine learning based data modeling for heart disease prediction
14. Computational biomedical sciences for renal disease management
15. Impact of machine learning in the prediction and prevention of
neurological diseases.
16. Telemedicine and internet-based advice to pregnant and nursing mothers
17. Effectiveness of telemedicine and internet-based diagnosis for the
prevention of adverse drug effects (ADRs).
18. Harvesting and growing of stem cells for regenerative medicine with
special reference to dermal disorders
19. Nanotechnology innovations for targeted delivery of multiple drugs in
cancer patients
20. Development of prolonged drug delivery systems for the treatment of
chronic diseases
21. Gold nanoparticles: A promising molecular probe for diagnostic
purposes, discovery of new therapies, cure for certain cancers, as well as
gene carriers and drug delivery vehicles
22. Impact of circadian rhythms in neurological disorders, cardiovascular
diseases, and diabetes mellitus
23. Role of Omics and metabolomics in drug discovery and drug delivery in
biomedical sciences
24. Pharmacogenetics in drug dose adjustments in the pediatric and elderly
populations
> 60 yrs.) and detection by apolipoprotein E genotyping.
Section III: Interventions and treatments across disease types
A: Role of microbiota in diseases
26. Pivotal role of healthy gut microbiota in the prevention of
non-communicable diseases (NCDs)
27. Emerging role of gut microbiomes in immunomodulation and colorectal
cancer
28. Influence of the gut microbiomes on cardiovascular health and
hypertension
29. Role of probiotics, prebiotics and symbiotic in the improvement of gut
microflora
30. Genetic, cellular and molecular biology germane to cardiovascular
ailments (e.g., coronary heart disease and stroke) and neurological
diseases (e.g., dementia, Alzheimer disease) in the ageing population
31. Molecular biology of chronic heart failure: Prevention and management
by antioxidant and anti-inflammation foods and phytotherapies
32. Therapeutic applications of human and bovine colostrum: Underlying
mechanisms of action
B: Challenges and interventions in NCDs
33. Environmental impact on cardiorespiratory and kidney related diseases
34. Pathophysiology of coronary heart disease: Role of the
renin-angiotensin and aldosterone system
35. Emerging respiratory problems including chronic obstructive pulmonary
disease (COPD)
36. Stroke: Causes, diagnosis and management by cholesterol lowering agents
and other suitable medicines
C: Challenges and interventions in infectious diseases
37. Emerging and re-emerging infectious diseases and challenges ahead
38. Tuberculosis: Molecular aspects in prediction, diagnosis and treatment
39. Viral hepatitis: its occurrence, diagnosis and management
40. Monkey pox and its impact on human health
41. Prophylactic vaccination strategies for the prevention of microbial
diseases with particular reference to COVID-19 on public health and health
care system
Section IV: Molecular medicine and nutrition
42. Clinical Nutrition in health promotion and well-being
43. Influence of nutraceuticals in health promotion and disease prevention
44. Biochemical, biophysical and therapeutic properties of functional foods
and Mediterranean diet
45. Traditional and novel fermented foods in the prevention of
non-communicable diseases (NCDs)
46. Clinical implications and mechanism of drug-drug and drug-food-herbal
interactions
???????Section V: Targeted therapies and strategies for the treatment of
acute and chronic diseases
47. Emerging trends in drug delivery systems: Scope and challenges
48. Role of Nanotechnology in the targeted delivery of anticancer drugs
49. Impact of Phamacometabolomics in new drug discovery and development of
novel therapies for the management of NCDs
50. Drug dose adjustment in elderly population using polypharmacy for
co-morbid conditions
51. Safety and efficacy assessment of new vaccines and their development
52. Antibiotic resistance and development alternative therapies
53. Drug regulatory requirements by the drug regulatory agencies
54. Post-marketing surveillance of drugs for monitoring adverse drug
reaction (ADRs)
55. Ethical issues and challenges in biomedical research
Section VI: Future perspectives in the development of novel technologies in
biomedicine and molecular medicine
delivery, and their roles in biomedical sciences Introduction and Preface
Section II: Technologies in biomedicine and molecular medicine
A: Basic and emerging technologies
1. Single-cell RNA-seq technologies in biomedical studies and their
potential clinical applications
2. Next-generation sequencing (NGS), OMICS and gene editing technologies:
Their role in biomedical sciences
3. Artificial intelligence in molecular medicine
4. Role of modern scientific technologies and innovations for augmenting
health care and precision in health care system
5. Machine Learning in the field of health care using medical images
6. Role of computer assisted prediction models in disease prevention
7. Physiological studies on the usefulness of chips
8. Bioinformatics as a tool for biomedical innovations
9. Molecular Epidemiological approach in disease management
10. Novel aspects of personalized medicines, patient care and management
11. Stem cells and Gene Therapy in disease management
12. Role of telemedicine in point of care treatment of patients
B: Application of technology in some diseases
13. Machine learning based data modeling for heart disease prediction
14. Computational biomedical sciences for renal disease management
15. Impact of machine learning in the prediction and prevention of
neurological diseases.
16. Telemedicine and internet-based advice to pregnant and nursing mothers
17. Effectiveness of telemedicine and internet-based diagnosis for the
prevention of adverse drug effects (ADRs).
18. Harvesting and growing of stem cells for regenerative medicine with
special reference to dermal disorders
19. Nanotechnology innovations for targeted delivery of multiple drugs in
cancer patients
20. Development of prolonged drug delivery systems for the treatment of
chronic diseases
21. Gold nanoparticles: A promising molecular probe for diagnostic
purposes, discovery of new therapies, cure for certain cancers, as well as
gene carriers and drug delivery vehicles
22. Impact of circadian rhythms in neurological disorders, cardiovascular
diseases, and diabetes mellitus
23. Role of Omics and metabolomics in drug discovery and drug delivery in
biomedical sciences
24. Pharmacogenetics in drug dose adjustments in the pediatric and elderly
populations
> 60 yrs.) and detection by apolipoprotein E genotyping.
Section III: Interventions and treatments across disease types
A: Role of microbiota in diseases
26. Pivotal role of healthy gut microbiota in the prevention of
non-communicable diseases (NCDs)
27. Emerging role of gut microbiomes in immunomodulation and colorectal
cancer
28. Influence of the gut microbiomes on cardiovascular health and
hypertension
29. Role of probiotics, prebiotics and symbiotic in the improvement of gut
microflora
30. Genetic, cellular and molecular biology germane to cardiovascular
ailments (e.g., coronary heart disease and stroke) and neurological
diseases (e.g., dementia, Alzheimer disease) in the ageing population
31. Molecular biology of chronic heart failure: Prevention and management
by antioxidant and anti-inflammation foods and phytotherapies
32. Therapeutic applications of human and bovine colostrum: Underlying
mechanisms of action
B: Challenges and interventions in NCDs
33. Environmental impact on cardiorespiratory and kidney related diseases
34. Pathophysiology of coronary heart disease: Role of the
renin-angiotensin and aldosterone system
35. Emerging respiratory problems including chronic obstructive pulmonary
disease (COPD)
36. Stroke: Causes, diagnosis and management by cholesterol lowering agents
and other suitable medicines
C: Challenges and interventions in infectious diseases
37. Emerging and re-emerging infectious diseases and challenges ahead
38. Tuberculosis: Molecular aspects in prediction, diagnosis and treatment
39. Viral hepatitis: its occurrence, diagnosis and management
40. Monkey pox and its impact on human health
41. Prophylactic vaccination strategies for the prevention of microbial
diseases with particular reference to COVID-19 on public health and health
care system
Section IV: Molecular medicine and nutrition
42. Clinical Nutrition in health promotion and well-being
43. Influence of nutraceuticals in health promotion and disease prevention
44. Biochemical, biophysical and therapeutic properties of functional foods
and Mediterranean diet
45. Traditional and novel fermented foods in the prevention of
non-communicable diseases (NCDs)
46. Clinical implications and mechanism of drug-drug and drug-food-herbal
interactions
???????Section V: Targeted therapies and strategies for the treatment of
acute and chronic diseases
47. Emerging trends in drug delivery systems: Scope and challenges
48. Role of Nanotechnology in the targeted delivery of anticancer drugs
49. Impact of Phamacometabolomics in new drug discovery and development of
novel therapies for the management of NCDs
50. Drug dose adjustment in elderly population using polypharmacy for
co-morbid conditions
51. Safety and efficacy assessment of new vaccines and their development
52. Antibiotic resistance and development alternative therapies
53. Drug regulatory requirements by the drug regulatory agencies
54. Post-marketing surveillance of drugs for monitoring adverse drug
reaction (ADRs)
55. Ethical issues and challenges in biomedical research
Section VI: Future perspectives in the development of novel technologies in
biomedicine and molecular medicine